148 related articles for article (PubMed ID: 3378354)
1. Accumulation of furancarboxylic acids in uremic serum as inhibitors of drug binding.
Niwa T; Takeda N; Maeda K; Shibata M; Tatematsu A
Clin Chim Acta; 1988 Apr; 173(2):127-38. PubMed ID: 3378354
[TBL] [Abstract][Full Text] [Related]
2. Efficient removal of albumin-bound furancarboxylic acid by protein-leaking hemodialysis.
Niwa T; Asada H; Tsutsui S; Miyazaki T
Am J Nephrol; 1995; 15(6):463-7. PubMed ID: 8546166
[TBL] [Abstract][Full Text] [Related]
3. Identification and quantification of a protein-bound ligand in uremic serum.
Takeda N; Niwa T; Tatematsu A; Suzuki M
Clin Chem; 1987 May; 33(5):682-5. PubMed ID: 3568353
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography.
Niwa T; Takeda N; Tatematsu A; Maeda K
Clin Chem; 1988 Nov; 34(11):2264-7. PubMed ID: 3141084
[TBL] [Abstract][Full Text] [Related]
5. Efficient removal of albumin-bound furancarboxylic acid, an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis.
Niwa T; Yazawa T; Kodama T; Uehara Y; Maeda K; Yamada K
Nephron; 1990; 56(3):241-5. PubMed ID: 2077405
[TBL] [Abstract][Full Text] [Related]
6. Reduced renal clearance of furancarboxylic acid, a major albumin-bound organic acid, in undialyzed uremic patients.
Sato M; Koyama M; Miyazaki T; Niwa T
Nephron; 1996; 74(2):419-21. PubMed ID: 8893167
[TBL] [Abstract][Full Text] [Related]
7. Determination of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, a major endogenous ligand substance in uremic serum, by high-performance liquid chromatography with ultraviolet detection.
Mabuchi H; Nakahashi H
J Chromatogr; 1987 Mar; 415(1):110-7. PubMed ID: 3584344
[No Abstract] [Full Text] [Related]
8. Inhibition of mitochondrial respiration by furancarboxylic acid accumulated in uremic serum in its albumin-bound and non-dialyzable form.
Niwa T; Aiuchi T; Nakaya K; Emoto Y; Miyazaki T; Maeda K
Clin Nephrol; 1993 Feb; 39(2):92-6. PubMed ID: 8448924
[TBL] [Abstract][Full Text] [Related]
9. Hippuric acid and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid in serum and urine. Analytical approaches and clinical relevance in kidney diseases.
Liebich HM; Bubeck JI; Pickert A; Wahl G; Scheiter A
J Chromatogr; 1990 Feb; 500():615-27. PubMed ID: 2329153
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatographic tandem mass spectrometric assay for the uremic toxin 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid in human plasma.
Huang Y; Sun H; Frassetto L; Benet LZ; Lin ET
Rapid Commun Mass Spectrom; 2006; 20(10):1611-4. PubMed ID: 16628600
[No Abstract] [Full Text] [Related]
11. Rapid assay for furancarboxylic acid accumulated in uremic serum using high-performance liquid chromatography and on-line mass spectrometry.
Niwa T; Kawagishi I; Ohya N
Clin Chim Acta; 1994 Apr; 226(1):89-94. PubMed ID: 8070137
[No Abstract] [Full Text] [Related]
12. Isolation and characterization of an endogenous drug-binding inhibitor present in uremic serum.
Mabuchi H; Nakahashi H
Nephron; 1986; 44(4):277-81. PubMed ID: 3796769
[TBL] [Abstract][Full Text] [Related]
13. A major inhibitor of phenytoin binding to serum protein in uremia.
Mabuchi H; Nakahashi H
Nephron; 1988; 48(4):310-4. PubMed ID: 3362278
[TBL] [Abstract][Full Text] [Related]
14. Determination of hippuric acid and furanic acid in serum of dialysis patients and control persons by high-performance liquid chromatography.
Pickert A; Bäuerle A; Liebich HM
J Chromatogr; 1989 Oct; 495():95-104. PubMed ID: 2613830
[TBL] [Abstract][Full Text] [Related]
15. [Plasma concentrations of anionic uremic toxins in hemodialysis patients and their effects on protein binding of pravastatin].
Ichimura Y; Takamatsu H; Ideuchi H; Oda M; Takeda K; Saitoh H
Yakugaku Zasshi; 2015; 135(6):821-8. PubMed ID: 26028417
[TBL] [Abstract][Full Text] [Related]
16. Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients?
Eloot S; Van Biesen W; Glorieux G; Neirynck N; Dhondt A; Vanholder R
PLoS One; 2013; 8(11):e76838. PubMed ID: 24236005
[TBL] [Abstract][Full Text] [Related]
17. Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremia.
Mabuchi H; Nakahashi H
Clin Chim Acta; 1987 Jul; 167(1):89-96. PubMed ID: 3665090
[TBL] [Abstract][Full Text] [Related]
18. Gas chromatographic and gas chromatographic-mass spectrometric analysis of organic acids in plasma of patients with chronic renal failure.
Liebich HM; Pickert A; Tetschner B
J Chromatogr; 1984 Apr; 289():259-66. PubMed ID: 6547446
[TBL] [Abstract][Full Text] [Related]
19. Measurement of furancarboxylic acid, a candidate for uremic toxin, in human serum, hair, and sweat, and analysis of pharmacological actions in vitro.
Sassa T; Matsuno H; Niwa M; Kozawa O; Takeda N; Niwa T; Kumada T; Uematsu T
Arch Toxicol; 2000 Feb; 73(12):649-54. PubMed ID: 10741476
[TBL] [Abstract][Full Text] [Related]
20. Displacement by anionic drugs of endogenous ligands bound to albumin in uremic serum.
Mabuchi H; Nakahashi H
Ther Drug Monit; 1988; 10(3):261-4. PubMed ID: 3140432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
